ARMATA PHARMACEUTICALS INC (ARMP) Stock Price & Overview
NYSEARCA:ARMP • US04216R1023
Current stock price
The current stock price of ARMP is 12.88 USD. Today ARMP is up by 10.18%. In the past month the price increased by 32.92%. In the past year, price increased by 947.15%.
ARMP Key Statistics
- Market Cap
- 471.794M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.66
- Dividend Yield
- N/A
ARMP Stock Performance
ARMP Stock Chart
ARMP Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ARMP. When comparing the yearly performance of all stocks, ARMP is one of the better performing stocks in the market, outperforming 99.61% of all stocks.
ARMP Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ARMP. Both the profitability and financial health of ARMP have multiple concerns.
ARMP Earnings
On March 25, 2026 ARMP reported an EPS of -3.27 and a revenue of 1.08M. The company missed EPS expectations (-1044.96% surprise) and beat revenue expectations (43.75% surprise).
ARMP Forecast & Estimates
8 analysts have analysed ARMP and the average price target is 15.3 USD. This implies a price increase of 18.79% is expected in the next year compared to the current price of 12.88.
For the next year, analysts expect an EPS growth of 76.14% and a revenue growth -100% for ARMP
ARMP Groups
Sector & Classification
ARMP Financial Highlights
Over the last trailing twelve months ARMP reported a non-GAAP Earnings per Share(EPS) of -4.66. The EPS decreased by -796.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -52.39% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ARMP Ownership
ARMP Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.18 | 371.899B | ||
| AMGN | AMGEN INC | 15.37 | 189.187B | ||
| GILD | GILEAD SCIENCES INC | 15.89 | 174.329B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.81 | 113.007B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.12 | 79.873B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 49.72 | 45.013B | ||
| INSM | INSMED INC | N/A | 33.111B | ||
| NTRA | NATERA INC | N/A | 30.421B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 29.133B | ||
| BIIB | BIOGEN INC | 11.1 | 26.264B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.79 | 25.357B | ||
| MRNA | MODERNA INC | N/A | 20.956B | ||
| INCY | INCYTE CORP | 12.62 | 19.441B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ARMP
Company Profile
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company is headquartered in Los Angeles, California and currently employs 60 full-time employees. The firm is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. The company is advancing two lead candidates, such as AP-PA02 and AP-SA02, to address both chronic and acute bacterial infections. Its lead phage candidate, inhaled AP-PA02, is focused primarily on the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.
Company Info
IPO: 1994-05-20
ARMATA PHARMACEUTICALS INC
5005 Mcconnell Ave
Los Angeles CALIFORNIA 90292 US
CEO: Todd R. Patrick
Employees: 60
Phone: 13106652928
ARMATA PHARMACEUTICALS INC / ARMP FAQ
What does ARMATA PHARMACEUTICALS INC do?
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company is headquartered in Los Angeles, California and currently employs 60 full-time employees. The firm is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. The company is advancing two lead candidates, such as AP-PA02 and AP-SA02, to address both chronic and acute bacterial infections. Its lead phage candidate, inhaled AP-PA02, is focused primarily on the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.
What is the current price of ARMP stock?
The current stock price of ARMP is 12.88 USD. The price increased by 10.18% in the last trading session.
What is the dividend status of ARMATA PHARMACEUTICALS INC?
ARMP does not pay a dividend.
What is the ChartMill rating of ARMATA PHARMACEUTICALS INC stock?
ARMP has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for ARMP stock?
8 analysts have analysed ARMP and the average price target is 15.3 USD. This implies a price increase of 18.79% is expected in the next year compared to the current price of 12.88.
What sector and industry does ARMATA PHARMACEUTICALS INC belong to?
ARMATA PHARMACEUTICALS INC (ARMP) operates in the Health Care sector and the Biotechnology industry.
Who owns ARMATA PHARMACEUTICALS INC?
You can find the ownership structure of ARMATA PHARMACEUTICALS INC (ARMP) on the Ownership tab.